Waltham, MA and Osaka, Japan, April 29, 2024 (PRNewswire) -- ONO Pharmaceutical, Co., Ltd., and Deciphera Pharmaceuticals, Inc., have...

In a landmark decision, the Federal Trade Commission (FTC) has voted 3-2 to approve the issuance of a final rule that could reshape the...

NY, NY, April 18, 2024 (Business Wire) -- Metsera, Inc., a pioneering player in the clinical-stage biopharmaceutical realm focusing on...

Cambridge, MA, April 23 2024 (PRNewswire) -- Flare Therapeutics Inc. has undergone a notable leadership transition with the selection...

Wilmington, DE, April 23, 2024 (RTTNews) -- Incyte Corp. (INCY) is buying Escient Pharmaceuticals and its assets for $750 million, plus...

Berkeley, CA, April 24, 2024 (PRNewswire) -- Actym Therapeutics announced the appointment of Thomas Smart as its new Chief Executive...

Austin, TX, April 19, 2024 (Lexology) -- Steris has entered into a contract to sell its dental division to private equity firm Peak...

San Diego, CA, April 3, 2024 (Reuters) -- Alterome Therapeutics announced that it has successfully secured $132 million. Spearheaded by...

Henderson, NV, April 8, 2024 (Zura Bio) -- Zura Bio, a company focused on advancing treatments for autoimmune and inflammatory...

Cambridge, MA, April 3, 2024 (Business Wire) -- Obsidian Therapeutics, Inc., a cutting-edge clinical-stage biotechnology company...

Basel, Switzerland, April 2, 2024 (Lonza) -- In a strategic move, Lonza has announced the appointment of Wolfgang Wienand as its new...

New Brunswick, NJ and Santa Clara, CA, April 5, 2024 (JNJ) -- Johnson & Johnson has entered into an agreement to purchase Shockwave...